A new trading day began on Tuesday, with Atossa Therapeutics Inc (NASDAQ: ATOS) stock price remained unchanged from the previous day of trading, before settling in for the closing price of $1.28. ATOS’s price has ranged from $0.67 to $2.31 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 11.46%. With a float of $125.75 million, this company’s outstanding shares have now reached $125.80 million.
Let’s determine the extent of company efficiency that accounts for 12 employees. In terms of profitability, gross margin is -27.78%, operating margin of -163827.78%, and the pretax margin is -149505.56%.
Atossa Therapeutics Inc (ATOS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Atossa Therapeutics Inc is 0.04%, while institutional ownership is 21.88%. The most recent insider transaction that took place on Apr 10 ’24, was worth 44,250. In this transaction Director of this company bought 25,000 shares at a rate of $1.77, taking the stock ownership to the 25,000 shares.
Atossa Therapeutics Inc (ATOS) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.06 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.46% per share during the next fiscal year.
Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators
Here are Atossa Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 13.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.25 in one year’s time.
Technical Analysis of Atossa Therapeutics Inc (ATOS)
Looking closely at Atossa Therapeutics Inc (NASDAQ: ATOS), its last 5-days average volume was 0.97 million, which is a drop from its year-to-date volume of 1.07 million. As of the previous 9 days, the stock’s Stochastic %D was 4.58%. Additionally, its Average True Range was 0.08.
During the past 100 days, Atossa Therapeutics Inc’s (ATOS) raw stochastic average was set at 33.33%, which indicates a significant increase from 3.80% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.69% in the past 14 days, which was higher than the 58.23% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4376, while its 200-day Moving Average is $1.3750. However, in the short run, Atossa Therapeutics Inc’s stock first resistance to watch stands at $1.3033. Second resistance stands at $1.3267. The third major resistance level sits at $1.3433. If the price goes on to break the first support level at $1.2633, it is likely to go to the next support level at $1.2467. Now, if the price goes above the second support level, the third support stands at $1.2233.
Atossa Therapeutics Inc (NASDAQ: ATOS) Key Stats
With a market capitalization of 161.03 million, the company has a total of 125,801K Shares Outstanding. Currently, annual sales are 0 K while annual income is -30,090 K. The company’s previous quarter sales were 0 K while its latest quarter income was -7,230 K.
